Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi H. | - |
dc.contributor.author | Jhun B.W. | - |
dc.contributor.author | Kim S.-Y. | - |
dc.contributor.author | Kim D.H. | - |
dc.contributor.author | Lee, Hyun | - |
dc.contributor.author | Jeon K. | - |
dc.contributor.author | Kwon O.J. | - |
dc.contributor.author | Huh H.J. | - |
dc.contributor.author | Ki C.-S. | - |
dc.contributor.author | Lee N.Y. | - |
dc.contributor.author | Shin S.J. | - |
dc.contributor.author | Daley C.L. | - |
dc.contributor.author | Koh W.-J. | - |
dc.date.accessioned | 2021-07-30T05:10:10Z | - |
dc.date.available | 2021-07-30T05:10:10Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2018-04 | - |
dc.identifier.issn | 0732-8893 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3364 | - |
dc.description.abstract | Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15%-20% of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93% (13/14) following antibiotic therapy. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.title | Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Hyun | - |
dc.identifier.doi | 10.1016/j.diagmicrobio.2017.12.008 | - |
dc.identifier.scopusid | 2-s2.0-85040340954 | - |
dc.identifier.wosid | 000428970100012 | - |
dc.identifier.bibliographicCitation | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, v.90, no.4, pp.293 - 295 | - |
dc.relation.isPartOf | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | - |
dc.citation.title | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | - |
dc.citation.volume | 90 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 293 | - |
dc.citation.endPage | 295 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.subject.keywordPlus | PULMONARY-DISEASE | - |
dc.subject.keywordPlus | SUBSP ABSCESSUS | - |
dc.subject.keywordPlus | ANTIBIOTIC-TREATMENT | - |
dc.subject.keywordPlus | ERM(41) GENE | - |
dc.subject.keywordPlus | MASSILIENSE | - |
dc.subject.keywordPlus | COMPLEX | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | BOLLETII | - |
dc.subject.keywordAuthor | Nontuberculous mycobacteria | - |
dc.subject.keywordAuthor | Mycobacterium abscessus | - |
dc.subject.keywordAuthor | Macrolides | - |
dc.subject.keywordAuthor | Drug resistance | - |
dc.subject.keywordAuthor | Treatment | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0732889317304042?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.